Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

NCT04752813 is registered in ClinicalTrials.gov with BPGbio as lead sponsor.

NCT NCT04752813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04752813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
Lead sponsor
BPGbio
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 22, 2022
Completion date
August 26, 2030
Enrollment
50 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, glioblastoma multiforme